Related content

Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia

By Boselli Emmanuel   Breilh Dominique   Cannesson Maxime   Xuereb Fabien   Rimmelé Thomas   Chassard Dominique   Saux Marie-Claude   Allaouchiche Bernard  

Intensive Care Medicine, Vol. 30, Iss. 5, 2004-05 ,pp. : 976-979

Springer Publishing Company

Access to resources Recommend Favorite

Glycine and ammonia plasma concentrations during sedation with remifentanil in critically ill patients

By Bonnet Marie-Pierre   Minville Vincent   Asehnoune Karim   Bridoux Delphine   Poggi-Bach Joséphine   Duranteau Jacques   Benhamou Dan  

Intensive Care Medicine, Vol. 33, Iss. 7, 2007-07 ,pp. : 1179-1182

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacokinetics of an Extended 4‐hour Infusion of Piperacillin‐Tazobactam in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy

By  

PHARMACOTHERAPY: THE JOURNAL OF HUMAN PHARMACOLOGY AND DRUG THERAPY, Vol. 35, Iss. 6, 2015-06 ,pp. : 600-607

John Wiley & Sons Inc

Access to resources Recommend Favorite

Point-of-Care Lung Ultrasound in Critically ill Patients

By  

Reviews on Recent Clinical Trials, Vol. 13, Iss. 1, 2018-01 ,pp. : 15-26

Bentham Science Publishers

Access to resources Recommend Favorite

Safety and Efficacy of Molgramostim as an Adjunctive Therapy in Critically Ill Patients with Severe Sepsis

By Myrianthefs Pavlos M.   Karabatsos Elias G.   Karatzas Stylianos P.   Boutzouka Eleni G.   Venetsanou Kyriaki F.   Evagelopoulou Penelope L.   Fildissis George A.   Legakis Nicolaos J.   Baltopoulos George J.  

Scandinavian Journal of Infectious Diseases, Vol. 35, Iss. 3, 2003-01 ,pp. : 175-179

Informa Healthcare

Access to resources Recommend Favorite